<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>INTRODUCTION: <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">Moyamoya</z:e> (MM) disease is a rare steno-occlusive cerebrovascular disease known to occur in children and adults </plain></SENT>
<SENT sid="1" pm="."><plain>The most serious complications in children are <z:hpo ids='HP_0001263'>developmental delay</z:hpo> and <z:hpo ids='HP_0001249'>mental retardation</z:hpo> due to recurrent hemodynamic <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>CASES: We report two pediatric patients without <z:hpo ids='HP_0003256'>coagulopathy</z:hpo> who suffered from severe arterio-embolic ischemic complications despite antiplatelet medication </plain></SENT>
<SENT sid="3" pm="."><plain>DISCUSSION: These observations underline the potential impact of cerebral <z:hpo ids='HP_0001907'>thromboembolism</z:hpo> on the pathophysiology of the <z:hpo ids='HP_0001297'>stroke</z:hpo> and thus on the treatment of children with MM disease </plain></SENT>
</text></document>